Nitric Oxide Synthase Inhibition as a Neuroprotective Strategy Following Hypoxic-Ischemic Encephalopathy: Evidence From Animal Studies

Favié, L. M. A. and Cox, A. R. and van den Hoogen, A. and Nijboer, C. H. A. and Peeters-Scholte, Cmpcd and van Bel, F. and Egberts, T. C. G. and Rademaker, C. M. A. and Groenendaal, F.

Front Neurol (2018) 9: 258

DOI: 10.3389/fneur.2018.00258

Abstract

BACKGROUND: Hypoxic-ischemic encephalopathy following perinatal asphyxia is a leading cause of neonatal death and disability worldwide. Treatment with therapeutic hypothermia reduced adverse outcomes from 60 to 45%. Additional strategies are urgently needed to further improve the outcome for these neonates. Inhibition of nitric oxide synthase (NOS) is a potential neuroprotective target. This article reviews the evidence of neuroprotection by nitric oxide (NO) synthesis inhibition in animal models. METHODS: Literature search using the EMBASE, Medline, Cochrane, and PubMed databases. Studies comparing NOS inhibition to placebo, with neuroprotective outcome measures, in relevant animal models were included. Methodologic quality of the included studies was assessed. RESULTS: 26 studies were included using non-selective or selective NOS inhibition in rat, piglet, sheep, or rabbit animal models. A large variety in outcome measures was reported. Outcome measures were grouped as histological, biological, or neurobehavioral. Both non-selective and selective inhibitors show neuroprotective properties in one or more outcome measures. Methodologic quality was either low or moderate for all studies. CONCLUSION: Inhibition of NO synthesis is a promising strategy for additional neuroprotection. In humans, intervention can only take place after the onset of the hypoxic-ischemic event. Therefore, combined inhibition of neuronal and inducible NOS seems the most likely candidate for human clinical trials. Future studies should determine its safety and effectiveness in neonates, as well as a potential sex-specific neuroprotective effect. Researchers should strive to improve methodologic quality of animal intervention studies by using a systematic approach in conducting and reporting of these studies.

Citation

Favié, L. M. A., Cox, A. R., van den Hoogen, A., Nijboer, C. H. A., Peeters-Scholte, C., van Bel, F., Egberts, T. C. G., Rademaker, C. M. A., & Groenendaal, F. (2018). Nitric Oxide Synthase Inhibition as a Neuroprotective Strategy Following Hypoxic-Ischemic Encephalopathy: Evidence From Animal Studies. Front Neurol, 9, 258. https://doi.org/10.3389/fneur.2018.00258 neuroprotection, animal models, review, 2-iminobiotin, hypoxic–ischemic encephalopathy, nitric oxide synthase inhibition

Keywords

• neuroprotection
• animal models
• review
• 2-iminobiotin
• hypoxic–ischemic encephalopathy
• nitric oxide synthase inhibition